The identification of genes that place individuals at high risk of breast,
ovarian, and colorectal cancer has greatly advanced our understanding of ca
ncer predisposition over the past decade. This knowledge has received much
attention from the media, and referrals to geneticists and surgeons, and re
quests for genetic testing, have risen. We review the published evidence fo
r the management of people at increased risk of hereditary cancers, to draw
attention to areas of uncertainty and to discuss implications for primary
care. We focus on common inherited cancers, since they will have the greate
st effect on clinical practice over the next decade. Cancer genetics offers
a model of how information on the genetics of other common diseases could
affect primary care in the future. Strategies to support the integration of
genetic medicine in primary care are needed to enable primary-care practit
ioners to identify individuals at raised genetic risk and to reassure patie
nts for whom genetic testing and increased surveillance offer little benefi
t.